Literature DB >> 19952959

The marginating-pulmonary immune compartment in rats: characteristics of continuous inflammation and activated NK cells.

Rivka Melamed1, Ella Rosenne, Marganit Benish, Yael Goldfarb, Ben Levi, Shamgar Ben-Eliyahu.   

Abstract

A significant role has been indicated for cellular immunity in controlling circulating cancer cells, but most autologous tumor cells seem resistant, in vitro, to natural killer cell (NKC) and cytotoxic T lymphocytes cytotoxicity. Addressing this apparent contradiction, we recently identified a unique leukocyte population, marginating-pulmonary (MP)-leukocytes, which exhibit potent natural killer (NK) cytotoxicity. Here, we characterize the MP-compartment in naive and immunostimulated rats, and assessed its cytotoxicity against "NK-resistant" tumors cells. Animals were treated with poly I-C (3x0.2 mg/kg) or saline, and circulating-leukocytes and MP-leukocytes were collected and analyzed in terms of cellular composition, cellular activation markers, and NK cytotoxicity of leukocytes and purified NKCs. Compared with circulating-leukocytes, MP-leukocytes showed greater proportion of granulocytes, monocytes, NKCs, and large NKCs; higher expression of activation and adhesion markers (CD25, CD11a, CD11b, and NKR-P1, IFN-gamma); and elevated NK cytotoxicity of leukocytes and purified NKCs against several syngeneic and xenogeneic NK-resistant target cells (from both F344 and BDX inbred rats). In immunostimulated animals (treated with poly I-C), but not in naive animals, purified NKCs from the MP-compartment showed markedly superior cytotoxicity, suggesting that poly I-C immunostimulation uniquely affect MP-NKCs, and that in naive animals other MP-leukocytes support NK cytotoxicity. Overall, the results suggest that the MP-compartment is characterized by a continuous activated inflammatory microenvironment uniquely affected by immunostimulation. If similarly potent MP-NKCs exist in patients, then circulating autologous tumor cells that are considered "NK-resistant" could actually be controlled by MP-NKCs. Innate immunity may assume greater role in controlling malignant spread, especially after immunostimulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19952959      PMCID: PMC2797825          DOI: 10.1097/CJI.0b013e3181b0b146

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  56 in total

1.  Kinetics of the early recruitment of leukocyte subsets at the sites of tumor cells in the lungs: natural killer (NK) cells rapidly attract monocytes but not lymphocytes in the surveillance of micrometastasis.

Authors:  Kiyoshi Shingu; Andreas Helfritz; Susanne Kuhlmann; Margot Zielinska-Skowronek; Roland Jacobs; Reinhold E Schmidt; Reinhard Pabst; Stephan von Hörsten
Journal:  Int J Cancer       Date:  2002-05-01       Impact factor: 7.396

Review 2.  A fresh look at tumor immunosurveillance and immunotherapy.

Authors:  M J Smyth; D I Godfrey; J A Trapani
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

Review 3.  Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens.

Authors:  Kirsty C Newman; Eleanor M Riley
Journal:  Nat Rev Immunol       Date:  2007-04       Impact factor: 53.106

4.  Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.

Authors:  N C Fernandez; A Lozier; C Flament; P Ricciardi-Castagnoli; D Bellet; M Suter; M Perricaudet; T Tursz; E Maraskovsky; L Zitvogel
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

5.  Inducing a mode of NK-resistance to suppression by stress and surgery: a potential approach based on low dose of poly I-C to reduce postoperative cancer metastasis.

Authors:  Ella Rosenne; Guy Shakhar; Rivka Melamed; Yossi Schwartz; Anat Erdreich-Epstein; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2006-12-16       Impact factor: 7.217

6.  Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection.

Authors:  Khuong B Nguyen; Thais P Salazar-Mather; Marc Y Dalod; Jeffrey B Van Deusen; Xiao-qing Wei; Foo Y Liew; Michael A Caligiuri; Joan E Durbin; Christine A Biron
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

7.  Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.

Authors:  T Barlozzari; J Leonhardt; R H Wiltrout; R B Herberman; C W Reynolds
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

8.  Regional differences in constitutive and induced ICAM-1 expression in vivo.

Authors:  J Panés; M A Perry; D C Anderson; A Manning; B Leone; G Cepinskas; C L Rosenbloom; M Miyasaka; P R Kvietys; D N Granger
Journal:  Am J Physiol       Date:  1995-12

9.  Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: possible role of oestradiol and natural killer cells.

Authors:  S Ben-Eliyahu; G G Page; G Shakhar; A N Taylor
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

10.  Lipopolysaccharide induced inflammation in the perivascular space in lungs.

Authors:  Thomas Tschernig; Kyathanahalli S Janardhan; Reinhard Pabst; Baljit Singh
Journal:  J Occup Med Toxicol       Date:  2008-07-30       Impact factor: 2.646

View more
  17 in total

1.  Continuous stress disrupts immunostimulatory effects of IL-12.

Authors:  Ben Levi; Marganit Benish; Yael Goldfarb; Liat Sorski; Rivka Melamed; Ella Rosenne; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2011-01-28       Impact factor: 7.217

2.  Maintaining unperturbed cerebral blood flow is key in the study of brain metastasis and its interactions with stress and inflammatory responses.

Authors:  Amit Benbenishty; Niva Segev-Amzaleg; Lee Shaashua; Rivka Melamed; Shamgar Ben-Eliyahu; Pablo Blinder
Journal:  Brain Behav Immun       Date:  2017-02-20       Impact factor: 7.217

3.  In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins.

Authors:  Ella Rosenne; Liat Sorski; Lee Shaashua; Elad Neeman; Pini Matzner; Ben Levi; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2013-12-12       Impact factor: 7.217

Review 4.  Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement.

Authors:  Elad Neeman; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2012-04-04       Impact factor: 7.217

5.  The misleading nature of in vitro and ex vivo findings in studying the impact of stress hormones on NK cell cytotoxicity.

Authors:  Neta Gotlieb; Ella Rosenne; Pini Matzner; Lee Shaashua; Liat Sorski; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2014-12-26       Impact factor: 7.217

6.  PGE2 suppresses NK activity in vivo directly and through adrenal hormones: effects that cannot be reflected by ex vivo assessment of NK cytotoxicity.

Authors:  G Meron; Y Tishler; L Shaashua; E Rosenne; B Levi; R Melamed; N Gotlieb; P Matzner; L Sorski; S Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2012-11-12       Impact factor: 7.217

7.  Selective Harvesting of Marginating-hepatic Leukocytes.

Authors:  Liat Sorski; Lee Shaashua; Rivka Melamed; Pini Matzner; Shamgar Ben-Eliyahu
Journal:  J Vis Exp       Date:  2016-07-21       Impact factor: 1.355

8.  Selective Harvesting of Marginating-pulmonary Leukocytes.

Authors:  Lee Shaashua; Liat Sorski; Rivka Melamed; Shamgar Ben-Eliyahu
Journal:  J Vis Exp       Date:  2016-03-11       Impact factor: 1.355

9.  A role for B cells in facilitating defense against an NK cell-sensitive lung metastatic tumor is revealed by stress.

Authors:  Harlan P Jones; Beau Aldridge; Katherine Boss-Williams; Jay M Weiss
Journal:  J Neuroimmunol       Date:  2017-11-03       Impact factor: 3.478

10.  Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effects.

Authors:  Pini Matzner; Liat Sorski; Lee Shaashua; Ely Elbaz; Hagar Lavon; Rivka Melamed; Ella Rosenne; Neta Gotlieb; Amit Benbenishty; Steve G Reed; Shamgar Ben-Eliyahu
Journal:  Int J Cancer       Date:  2015-10-26       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.